Literature DB >> 26044082

Characterization of HLA-G and Related Immunosuppressive Effects in Human Umbilical Cord Stroma-Derived Stem Cells.

Dah-Ching Ding1, Hsiang-Lan Chou, Yu-Hsun Chang, Wei-Ting Hung, Hwan-Wun Liu, Tang-Yuan Chu.   

Abstract

Mesenchymal stem cells (MSCs) and especially those derived from fetal tissues exert a potent immunosuppressive effect that can be enhanced under inflammatory conditions. This study aimed to explore the immunosuppressive properties of human umbilical cord mesenchymal stem cells (HUCMSCs). We found that HLA-G, the nonclassical HLA allele with strong immune-inhibitory properties, was much more expressed on the HUCMSCs than on MSCs of other origins. Flow cytometry revealed that 90.8% of the HUCMSCs expressed HLA-G. RT-PCR revealed expression of HLA-G1, HLA-G5, and HLA-G7 in all of four HUCMSC lines. In a mixed lymphocyte reaction assay, the HUCMSCs inhibited the proliferation of lymphocytes by 35 ± 3% and could be reversed by treatment with an HLA-G blocking antibody. Upon coculture with the HUCMSCs, peripheral blood mononuclear cells expressed lower levels of proinflammatory mediators such as IL-6, TNF-α, and VEGF-α. This immunosuppressive effect was enhanced when the HUCMSCs were pretreated with IFN-γ, such that the expression of HLA-G was highly activated and HLA-DR diminished. The same phenomenon was not observed in MSCs derived from bone marrow or the placenta. In a xenograft rejection assay, the HUCMSCs survived in immunocompetent mice, whereas primary fibroblasts did not survive. This study confirms the HLA-G-related immunosuppressive property of HUCMSCs, which is more potent than MSCs of other origin. A good tolerance of this mesenchymal stem cell in allogeneic transplantation can thus be anticipated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26044082     DOI: 10.3727/096368915X688182

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  20 in total

1.  Umbilical cord-derived mesenchymal stem cells for treating osteoarthritis of the knee: a single-arm, open-label study.

Authors:  Ismail Hadisoebroto Dilogo; Anissa Feby Canintika; Alberto Lastiko Hanitya; Jeanne Adiwinata Pawitan; Isabella Kurnia Liem; Jacub Pandelaki
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-01-27

2.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

3.  Mesenteric injection of adipose-derived mesenchymal stem cells relieves experimentally-induced colitis in rats by regulating Th17/Treg cell balance.

Authors:  Zheng-Wei Fu; Zhen-Yu Zhang; Hai-Yan Ge
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

4.  Human Umbilical Cord Mesenchymal Stem Cells for Severe Neurological Sequelae due to Anti-N-Methyl-d-Aspartate Receptor Encephalitis: First Case Report.

Authors:  Liem Nguyen Thanh; Van T Hoang; Huong Le Thu; Phuong Anh Thi Nguyen; Duc M Hoang; Doan Van Ngo; Hung Cao Vu; Van Nguyen Thi Bich; Michael Heke
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

Review 5.  Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System.

Authors:  Vivien J Coulson-Thomas; Yvette M Coulson-Thomas; Tarsis F Gesteira; Winston W-Y Kao
Journal:  Ocul Surf       Date:  2016-01-12       Impact factor: 5.033

6.  Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice.

Authors:  Gianluca Moroncini; Chiara Paolini; Fiorenza Orlando; Chiara Capelli; Antonella Grieco; Cecilia Tonnini; Silvia Agarbati; Eleonora Mondini; Stefania Saccomanno; Gaia Goteri; Silvia Svegliati Baroni; Mauro Provinciali; Martino Introna; Nicoletta Del Papa; Armando Gabrielli
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

Review 7.  Xenogeneic stem cell transplantation: Research progress and clinical prospects.

Authors:  Lin-Li Jiang; Hui Li; Lei Liu
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

8.  Pigment epithelium-derived factor from ARPE19 promotes proliferation and inhibits apoptosis of human umbilical mesenchymal stem cells in serum-free medium.

Authors:  Dah-Ching Ding; Yao-Tseng Wen; Rong-Kung Tsai
Journal:  Exp Mol Med       Date:  2017-12-15       Impact factor: 8.718

9.  Comparison of Immunological Characteristics of Mesenchymal Stem Cells from the Periodontal Ligament, Umbilical Cord, and Adipose Tissue.

Authors:  Jin-Hee Kim; Chris H Jo; Hang-Rae Kim; Young-Il Hwang
Journal:  Stem Cells Int       Date:  2018-04-01       Impact factor: 5.443

10.  Human umbilical cord-derived mesenchymal stem cells reduce monosodium iodoacetate-induced apoptosis in cartilage.

Authors:  Yu-Hsun Chang; Kun-Chi Wu; Hwan-Wun Liu; Tang-Yuan Chu; Dah-Ching Ding
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.